- Release Date: 05/03/26 08:31
- Summary: SPONTAN Phase II Clinical Study Completes Recruitment
- Price Sensitive: Yes
- Download Document 149.67KB
- Forums
- ASX - By Stock
- LTP
- Ann: SPONTAN Phase II Clinical Study Completes Recruitment
LTP
ltr pharma limited
Add to My Watchlist
1.25%
!
40.5¢
Ann: SPONTAN Phase II Clinical Study Completes Recruitment
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
Last
40.5¢ |
Change
0.005(1.25%) |
Mkt cap ! $72.71M | |||
| Open | High | Low | Volume |
| 40.0¢ | 41.5¢ | 40.0¢ | 299.6K |
Buyers (Bids)
| Vol. | Price($) |
|---|---|
| 104897 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. |
|---|---|
| 41.5¢ | 12029 |
| Last trade - 16.10pm 15/04/2026 (20 minute delay) ? |
Featured News
NEWS
HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster
AII
Almonty Establishes U.S. Corporate Headquarters, Reinforcing Role as America's Tungsten Supplier
| LTP (ASX) Chart |
The Watchlist
OR3
ORE RESOURCES LIMITED
Nicholas Rathjen, Managing Director
Nicholas Rathjen
Managing Director
SPONSORED BY The Market Online